Table 3.

Grade 2 and above AEs at least possibly related to neratinib (N = 16)

AEGrade 2, N (%)Grade 3, N (%)Total, N (%)
Diarrhea7 (44%)4 (25%)*11 (69%)
Anorexia7 (44%)07 (44%)
Fatigue4 (25%)1 (6%)5 (31%)
Anemia3 (19%)03 (19%)
Nausea3 (19%)03 (19%)
Dehydration1 (6%)1 (6%)2 (13%)
Dyspepsia2 (13%)02 (13%)
Hypophosphatemia2 (13%)02 (13%)
Vomiting2 (13%)02 (13%)
Syncope01 (6%)1 (6%)
  • NOTE: AEs that are grade 2 or above experienced by more than one patient or any occurrence of grade 3 AEs are included.